Investigating Medication vs. Prostatic Urethral Lift: Assessment and Comparison of Therapies for BPH

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This prospective, multicenter, two-arm, 1:1 randomized controlled trial (RCT) will enroll approximately 250 males at approximately 25 sites located within the United States. All enrolled subjects will be 45 years of age or older diagnosed with symptomatic benign prostatic hyperplasia (BPH). They will be randomized to one of two readily available, marketed BPH therapies; Prostatic Urethral Lift procedure with the UroLift System (PUL Arm) or 0.4mg tamsulosin HCl (MED Arm).
Epistemonikos ID: e1bda39d6a2f2131474d987258a55bee5aedec40
First added on: May 09, 2024